Combined angiotensin receptor and neprilysin inhibition therapy for heart failure.

Lu, Becky N; Davis, Lindsay E

Lu, Becky N; Davis, Lindsay E.

Affiliation

Lu BN; At the time this article was written, Becky N. Lu was a student at Midwestern University College of Pharmacy in Glendale, Ariz. Lindsay E. Davis is an associate professor at Midwestern University. The authors have disclosed no potential conflicts of interest, financial or otherwise.

JAAPA ; 31(7): 35-37, 2018 Jul.

Article in En | MEDLINE | ID: mdl-29957605

Subject(s)

Aminobutyrates/therapeutic use; Angiotensin Receptor Antagonists/therapeutic use; Heart Failure, Systolic/drug therapy; Tetrazoles/therapeutic use; Biphenyl Compounds; Drug Combinations; Heart Failure/drug therapy; Humans; Randomized Controlled Trials as Topic; Renin-Angiotensin System/drug effects; Treatment Outcome; Valsartan

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tetrazoles / Heart Failure, Systolic / Angiotensin Receptor Antagonists / Aminobutyrates Type of study: Clinical_trials Limits: Humans Language: En Journal: JAAPA Journal subject: MEDICINA Year: 2018 Type: Article

Fulltext

XML

PubMed Links

Search on Google